arrow
J

Janett Fischer

University of Toronto
H指数:28
被引数:3,340

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Soluble Urokinase Plasminogen Activator Receptor is a prognostic biomarker in decompensated liver cirrhosis

可溶性尿激酶型纤溶酶原激活剂受体是失代偿期肝硬化的预后生物标志物

2025-11-110
OAAI
Prospective Analysis of Safety and Efficacy of Tenofovir Alafenamide Fumarate (TAF) in European Real-World Patients with Chronic Hepatitis B: A Single-Centre Real-Word Cohort Study

欧洲真实世界慢性乙型肝炎患者的替诺福韦阿拉酚胺富马酸盐 (TAF) 的安全性和有效性的前瞻性分析: 单中心实时队列研究

2024-09-230
OAAI
Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients

欧洲DAA经验患者的罕见HCV亚型和再治疗结果

2024-07-010
OAAI
Association of Alpha-1 Antitrypsin Pi*Z Allele Frequency and Progressive Liver Fibrosis in Two Chronic Hepatitis C Cohorts

在两个慢性丙型肝炎队列中,α-1抗胰蛋白酶Pi * Z等位基因频率与进行性肝纤维化的关联

2022-12-293
OAAI
The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With Cirrhosis
2021-12-2713
OAAI
Copy number variation and expression of exportin-4 associates with severity of fibrosis in metabolic associated fatty liver disease
2021-08-0116
OAAI
Mistranslation Drives Alterations in Protein Levels and the Effects of a Synonymous Variant at the Fibroblast Growth Factor 21 Locus
2021-05-0120
OAAI
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores

使用多基因风险评分对非酒精性脂肪肝的肝细胞癌风险进行非侵入性分层

2021-04-01226
OAAI
Variants in PCSK7, PNPLA3 and TM6SF2 are risk factors for the development of cirrhosis in hereditary haemochromatosis
2021-02-108
OA
Genome-Wide Association Study for Alcohol-Related Cirrhosis Identifies Risk Loci in MARC1 and HNRNPUL1
2020-10-0158
OAAI
Extrahepatic autoimmune diseases in primary biliary cholangitis: Prevalence and significance for clinical presentation and disease outcome
2020-08-2348
PREAI
Genetic Variation in HSD17B13 Reduces the Risk of Developing Cirrhosis and Hepatocellular Carcinoma in Alcohol Misusers
2020-05-2090
OAAI